Development of Interdisciplinary Database Program For Patients with Heart Failure at Heart Failure Clinic, Udonthani Hospital
Keywords:
Data recording program, database, heart failure, interdisciplinaryAbstract
This research and development study aimed to develop and study The Development of interdisciplinary database program for patients with heart failure at heart failure clinic, Udonthani Hospital. The study was carried out in 3 phases during July 2022 - January 2023. Phase 1 was a situational analysis of current data recordings. Phase 2 was followed to develop a database program and evaluation of the program’s effects was completed in Phase 3. Subjects consisted of 2 groups including 15 interdisciplinary health personnel and 100 medical records of patients with heart failure. Research instruments included program effects questionnaire, medical record completeness checklist and user satisfaction questionnaire.
Result; phase 1 revealed that health personnel did not have an electronic database and recorded data independently which resulted in redundant and incomplete data. In phase 2, data recording program was developed for physicians, nurses, pharmacists, physical therapists and nutritionists to share and use to record information such as patients risk stratification, 6MWT METs, quality of life, nutrition behavior, drug compliance, and GDMT checklist. In phase 3, the database program was use to record patients information and found that the program had an average overall effectiveness (x̄ =4.5, S.D.=0.6). The proportion of data completeness increased significantly from 86% (95% CI = 0.93-1.07) in the year 2022 to 93% in 2023 (95% CI 0.87-0.98), p=0.04. Health personnel rate high level of satisfaction with the program (x̄ =4.6,S.D.=0.5). These results indicated that the database program is effective and feasible to be used in the heart failure clinic.
References
Metra M, Teerlink JR. Heart failure. Lancet 2017; 390(10106): 1981-1995.
Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020; 22(8): 1342-1356.
อรวิกาญจน์ ชัยมงคล, ศริญญา ภูวนันท์และศุทธิจิต ภูมิวัฒนะ. บทความวิชาการบทบาทพยาบาลในการดูแลผู้ป่วยภาวะหัวใจล้มเหลว ณ หน่วยบริการผู้ป่วยนอก. วชิรสารการพยาบาล 2565; 24(1): 75-95
Laothavorn P, Hengrussamee K, Kanjanavanit R, Moleerergpoom W, Laorakpongse D, Pachirat O, et al. Thai acute decompensated heart failure registry (Thai ADHERE). CVD prevention and control 2010; 5(3): 89-95.
งานเวชสถิติโรงพยาบาลอุดรธานี. ข้อมูลสถิติโรคหัวใจล้มเหลว. อุดรธานี: โรงพยาบาลอุดรธานี; 2565.
Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail 2022; 28(5): e1-e167.
Sim KS, Chong SS, Tso CP, Nia ME, Chong AK, Abbas SF. Computerized database management system for breast cancer patients. Springer plus 2014; 27(3): 268.
Kodama K, Sakamoto T, Kubota T, Takimura H, Hongo H, Chikashima H, et al. Construction of a Heart Failure Database Collating Administrative Claims Data and Electronic Medical Record Data to Evaluate Risk Factors for In-Hospital Death and Prolonged Hospitalization. Circ Rep 2019; 1(12): 582-592.
วรนิษฐา ธรรมขัน, วราภรณ์ บุญเชียง, อักษรา ทองประชุม, เอกรัฐ บุญเชียง. การพัฒนาโปรแกรมสารสนเทศการจัดการข้อมูลผู้ป่วยโรคหลอดเลือดสมอง โรงพยาบาลฮอดจังหวัดเชียงใหม่. ว.วิจัยการพยาบาลและการสาธารสุข 2564; 1(2): 42-56.
มาลีวัลย์ ศรีวิลัย. การพัฒนารูปแบบระบบฐานข้อมูลสาธารณสุข จังหวัดเชียงราย. ว.สาธารณสุขล้านนา 2017; 13(1): 14-24.
Chow, Shein-Chung, Jun Shao, Hansheng Wang. In vitro bioequivalence testing. Statistics in medicine 2003; 55-68.
บุญชม ศรีสะอาด. การวิจัยเบื้องต้น. พิมพ์ครั้งที่ 9. กรุงเทพฯ: สุวีริยาสาส์น; 2556. หน้า 120-121.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42(36): 3599-3726.
Jaarsma T, Hill L, Bayes-Genis A, La Rocca HB, Castiello T, Celutkiene J, et al. Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021; 23(1): 157-174.
Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993; 71(12): 1106-7.
Vellone E, De Maria M, Iovino P, Barbaranelli C, Zeffiro V, Pucciarelli G, Durante A, et al. The Self-Care of Heart Failure Index version 7.2: Further psychometric testing. Res Nurs Health 2020; 43(6): 640-650.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al ; Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18(8): 891-975.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am CollCardiol 2016; 68(13): 1476-1488.
Maddox TM, Januzzi JL, Allen LA, Breathett K, Butler J, Davis L. Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. J Am CollCardiol 2021; 77(6): 772-810.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021; 42(36): 3599-3726.
Deka P, Pozehl BJ, Pathak D, Williams M, Norman JF, Alonso WW, Jaarsma T. Predicting maximal oxygen uptake from the 6 min walk test in patients with heart failure. ESC Heart Fail 2021; 8(1): 47-54.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
การละเมิดลิขสิทธิ์ถือเป็นความรับผิดชอบของผู้ส่งบทความโดยตรง
ผลงานที่ได้รับการตีพิมพ์ถือเป็นลิขสิทธิ์ของผู้นิพนธ์ ขอสงวนสิทธิ์มิให้นำเนื้อหา ทัศนะ หรือข้อคิดเห็นใด ๆ ของบทความในวารสารไปเผยแพร่ทางการค้าก่อนได้รับอนุญาตจากกองบรรณาธิการ อย่างเป็นลายลักษณ์อักษร
